ASB14780, an Orally Active Inhibitor of Group IVA Phospholipase A2, Is a Pharmacotherapeutic Candidate for Nonalcoholic Fatty Liver Disease.
| Image |  |
|---|---|
| Description | scientific article published on 23 December 2015 |
| Author/s |
author: Keiichi Ishihara Toshiyuki Tomoo |
| Publication date | December 23, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |